Merck has reported a significant increase in net income attributable to shareholders, reaching $4.76bn in the first quarter ...

Robotics company Multiply Labs has partnered with global life-sciences service provider GenScript Biotech to automate the ...

AstraZeneca has reported profit after tax of $2.18bn for the first quarter (Q1) of 2024, a notable rise from $1.80bn reported ...

The Series B extension proceeds will fund Phase III trial for Cerevance’s lead CNS therapy, CVN424, in patients with ...

The IRA adds another hurdle to an already challenging research landscape, according to a study from the Pioneer Institute.

Regeneron Pharmaceuticals has collaborated with Mammoth Biosciences to develop in vivo clustered regularly interspaced short ...

A Senate Committee is investigating the “outrageously high” US price tags of the blockbuster diabetes and obesity drugs.

The US Food and Drug Administration (FDA) has approved Utility Therapeutics’ Pivya tablets, a new treatment for female adults ...

In Germany, new measures have come into effect as part of the GKV-FinStG Act in 2022 that put into question this market’s ...

Tislelizumab is greenlit as a first-line treatment in combination with certain drugs in non-small cell lung cancer.

The US Food and Drug Administration (FDA) has granted approval for ImmunityBio's ANKTIVA, plus Bacillus Calmette-Guérin (BCG) ...

Mundipharma has signed an agreement to acquire all assets and rights related to antifungal candidate REZZAYO (rezafungin) ...